• <nav id="c8c2c"></nav>
      • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
      • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
      • <nav id="c8c2c"><sup id="c8c2c"></sup></nav>
        <tr id="c8c2c"></tr>
      • a级毛片av无码,久久精品人人爽人人爽,国产r级在线播放,国产在线高清一区二区

          Home>News Center>China
               
         

        Four Beijing volunteers test SARS vaccine
        By Liang Chao (China Daily)
        Updated: 2004-05-24 07:47

        China started its first human trials for a new SARS vaccine on Saturday with four volunteers, the first batch of the 30 selected, being vaccinated in a hospital in Beijing.


        President Hu Jintao visits doctors and nurses in a Sichuan hospital during last year's SARS outbreak. [newsphoto/file]

        "The four volunteers calmly received vaccination against severe acute respiratory syndrome (SARS) in the heavily guarded second-floor of the China-Japan Friendship Hospital," Xinhua reported.

        The vaccine used for the volunteers was produced by Beijing-based Sinovac Biotech Co Ltd, a company authorized by the State Food and Drug Administration (SFDA).

        The vaccine was found to be safe and effective in experiments on animals, including the rhesus monkey, which has a more similar immune system to humans than other animals.


        Medical workers obtain a saliva sample from a dead civet cat at the Guangzhou Sanitarian Treatment Factory in South China's Guangdong Province January 7, 2004. [newsphoto/file]

        The first phase of the test is to determine if it is safe and effective for humans. There were still risks, experts said.

        A special committee has been set up to protect the rights of the volunteers, who may participate or withdraw from the test at will.

        Researchers will provide medical treatment if the volunteers suffer any adverse effects.

        The second phase of clinical testing will involve more participants.

        In February, the SFDA authorized Sinovac to select volunteers for China's first clinical testing of the vaccine. It only sets the standard number of volunteers needed for the first clinical testing, but does not select the actual volunteers.

        The first phase of the testing will last three months in Beijing, South China's Guangdong Province or the Guangxi Zhuang Autonomous Region.

         
          Today's Top News     Top China News
         

        Four Beijing volunteers test SARS vaccine

         

           
         

        Chengdu axes 16 ineffective officials

         

           
         

        Guangzhou delays metro launch

         

           
         

        Koizumi returns with abductees' 5 kids

         

           
         

        Juveniles fall under new prosecution rule

         

           
         

        Documents: Abuse was to punish and amuse

         

           
          Juveniles fall under new prosecution rule
           
          Guangzhou delays metro launch
           
          Chengdu axes 16 ineffective officials
           
          Four Beijing volunteers test SARS vaccine
           
          Chinese patrol vessel to attend exercise in Japan
           
          Chinese killed in Paris airport roof collapse
           
         
          Go to Another Section  
         
         
          Story Tools  
           
          Related Stories  
           
        China's last SARS patient leaves hospital
           
        WHO: China's SARS outbreak contained
           
        SARS patient in Anhui discharged
           
        Researcher: Sweat may transmit SARS virus
           
        WHO works with China on SARS, bird flu vaccines
           
        SARS vaccine enters testing
          News Talk  
          When will china have direct elections?  
        Advertisement
                 
        a级毛片av无码
        • <nav id="c8c2c"></nav>
          • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
          • <tfoot id="c8c2c"><noscript id="c8c2c"></noscript></tfoot>
          • <nav id="c8c2c"><sup id="c8c2c"></sup></nav>
            <tr id="c8c2c"></tr>